Want to track TOIIW and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
This company has been delisted from its primary exchange and is no longer publicly traded.
As a result, real-time price data, dividend updates, and corporate disclosures may no longer be available.
TOIIW Chart
The Oncology Institute Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| PMM Phillip M. Meyer Oasis Management Co. Ltd. | 100,000 | $12,000 | $5,000 | -$7,000 | -58.33% |
| BO Brian Oliveira Clear Street Group Inc. | 6,028 | $707.78 | $301.4 | -$406.38 | -57.42% |
The Oncology Institute Inc. (TOIIW) FAQ
What does "Delisted" mean?
The Oncology Institute Inc. has been removed from the exchange and is no longer publicly traded.
What was the last recorded dividend?
No dividend payments were recorded prior to delisting.
How long did the company pay dividends?
The company did not have a dividend payment history.
Were there any stock splits?
No stock splits were recorded prior to delisting.
What was the last known trading price?
The stock last traded at $0.05 on Aug 03, 2026 before being delisted.
The Oncology Institute Inc. Profile
| Health Care Providers & Services Industry | Healthcare Sector | Daniel Virnich CEO | NASDAQ (CM) Exchange | 68236X118 CUSIP |
| US Country | 641 Employees | - Last Dividend | - Last Split | 4 Jun 2020 IPO Date |
Overview
The Oncology Institute, Inc. is a specialized oncology company based in the United States, known for providing comprehensive medical oncology services. Founded in 2007 and headquartered in Cerritos, California, the institute is dedicated to offering a wide range of oncology care, including advanced treatments and supportive services for cancer patients. The company's approach integrates innovative therapies and patient support programs to ensure holistic care for those battling cancer.
Products and Services
The Oncology Institute, Inc. offers a variety of oncology services designed to meet the comprehensive needs of cancer patients:
- Physician Services: The institute boasts a team of experienced oncology professionals providing expert diagnosis, treatment planning, and ongoing management of cancer.
- In-house Infusion and Dispensary: Patients have access to in-house infusion services for chemotherapy and other medications, along with a dispensary for necessary prescriptions, offering convenience and integrated care.
- Clinical Trial Services: The Oncology Institute leads and manages clinical trials, offering patients access to cutting-edge treatments and therapies under professional supervision.
- Outpatient Stem Cell Transplants and Transfusions Programs: These programs offer advanced treatments for suitable candidates, providing critical services in a patient-centered, outpatient setting.
- Patient Support: Recognizing the challenges that come with a cancer diagnosis, the institute provides comprehensive support services aimed at improving the quality of life for patients and their families.
Contact Information
Address: 18000 Studebaker Road
Phone: 213 760 1328
Website: https://theoncologyinstitute.com
2026 © Marketlog. All Rights Reserved.
